search
Back to results

A Trial of Thickened Feeds to Treat Gastroesophageal Reflux in Children Admitted After Choking Spell

Primary Purpose

Apparent Life Threatening Event, Gastroesophageal Reflux, Aspiration

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Rice cereal
Enfamil AR
Sponsored by
Boston Children's Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Apparent Life Threatening Event focused on measuring Brief resolved unexplained event

Eligibility Criteria

0 Years - 1 Year (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients less than 12 months of age who have been admitted to the hospital after brief resolved unexplained event

Exclusion Criteria:

  • Patients with any pre-existing significant medical diagnosis (congenital heart disease, known neurologic impairment with or without seizure disorder, other congenital anomalies)
  • Patients with any prior hospitalization for BRUE
  • Patients with food allergies such that they cannot be on a milk or rice based diet
  • Any patient exclusively breastfed because change to a formula or adding thickening is not possible unless patients choose to pump breast milk and stop all nursing

Sites / Locations

  • Boston Children's Hospital

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

No Intervention

Experimental

Experimental

Arm Label

Standard Formula

Standard Formula with Rice Cereal

Enfamil AR

Arm Description

This is the group of subjects randomized to receive their standard formula

This is the group of subjects randomized to receive their standard formula with rice cereal added

This is the group of subjects randomized to receive Enfamil AR

Outcomes

Primary Outcome Measures

Choking episodes
Frequency of choking episodes

Secondary Outcome Measures

Choking episodes
Frequency of choking episodes
Repeat hospital admission
Number of hospitalizations after randomization
Microbiome changes
Prior studies have suggested that infant thickeners can be associated with necrotizing enterocolitis in infants; the aim of this secondary outcome measure will be to evaluate for changes in microbiome (particularly toward a more pathogenic microbiome) after randomization
Urine concentration
Change in urine concentration after randomization

Full Information

First Posted
March 6, 2017
Last Updated
April 2, 2021
Sponsor
Boston Children's Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03130543
Brief Title
A Trial of Thickened Feeds to Treat Gastroesophageal Reflux in Children Admitted After Choking Spell
Official Title
A Randomized Trial of Thickened Feeds to Treat Gastroesophageal Reflux in Children Admitted to Boston Children's Hospital After Brief Resolved Unexplained Event
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Terminated
Why Stopped
Focusing on observational cohort study due to limited enrollment in trial
Study Start Date
April 24, 2017 (Actual)
Primary Completion Date
April 2, 2021 (Actual)
Study Completion Date
April 2, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Boston Children's Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Infants often present to the hospital with episodes of coughing, choking, gagging, change in muscle tone, and/or change in skin color, known as brief resolved unexplained event. Many studies have tried to address why infants have these symptoms and if there is a way to prevent them from happening again. Currently, there is no clear agreement on the most common cause of these symptoms or how to prevent them. Some studies have suggested that gastroesophageal reflux can cause these symptoms. The investigators are conducting a study of infants who are admitted to Boston Children's Hospital with episodes of coughing, choking, gagging, change in muscle tone, and/or change in skin color, symptoms that could be reflux. The investigators want to determine if these symptoms can be prevented by changing the way infants are fed, either by giving them a formula to treat reflux or by thickening their feeds to treat reflux. The goal of the study is to determine if different types of feeding interventions prevent infants from coming back to the hospital.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Apparent Life Threatening Event, Gastroesophageal Reflux, Aspiration
Keywords
Brief resolved unexplained event

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
3 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Standard Formula
Arm Type
No Intervention
Arm Description
This is the group of subjects randomized to receive their standard formula
Arm Title
Standard Formula with Rice Cereal
Arm Type
Experimental
Arm Description
This is the group of subjects randomized to receive their standard formula with rice cereal added
Arm Title
Enfamil AR
Arm Type
Experimental
Arm Description
This is the group of subjects randomized to receive Enfamil AR
Intervention Type
Dietary Supplement
Intervention Name(s)
Rice cereal
Intervention Description
Standard formula thickened with rice cereal
Intervention Type
Dietary Supplement
Intervention Name(s)
Enfamil AR
Intervention Description
Enfamil AR formula
Primary Outcome Measure Information:
Title
Choking episodes
Description
Frequency of choking episodes
Time Frame
2 weeks
Secondary Outcome Measure Information:
Title
Choking episodes
Description
Frequency of choking episodes
Time Frame
12 months
Title
Repeat hospital admission
Description
Number of hospitalizations after randomization
Time Frame
12 months
Title
Microbiome changes
Description
Prior studies have suggested that infant thickeners can be associated with necrotizing enterocolitis in infants; the aim of this secondary outcome measure will be to evaluate for changes in microbiome (particularly toward a more pathogenic microbiome) after randomization
Time Frame
2 months
Title
Urine concentration
Description
Change in urine concentration after randomization
Time Frame
2 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
0 Years
Maximum Age & Unit of Time
1 Year
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients less than 12 months of age who have been admitted to the hospital after brief resolved unexplained event Exclusion Criteria: Patients with any pre-existing significant medical diagnosis (congenital heart disease, known neurologic impairment with or without seizure disorder, other congenital anomalies) Patients with any prior hospitalization for BRUE Patients with food allergies such that they cannot be on a milk or rice based diet Any patient exclusively breastfed because change to a formula or adding thickening is not possible unless patients choose to pump breast milk and stop all nursing
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rachel L Rosen, MD, MPH
Organizational Affiliation
Boston Children's Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Boston Children's Hospital
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02115
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
27741062
Citation
Duncan DR, Amirault J, Mitchell PD, Larson K, Rosen RL. Oropharyngeal Dysphagia Is Strongly Correlated With Apparent Life-Threatening Events. J Pediatr Gastroenterol Nutr. 2017 Aug;65(2):168-172. doi: 10.1097/MPG.0000000000001439.
Results Reference
background

Learn more about this trial

A Trial of Thickened Feeds to Treat Gastroesophageal Reflux in Children Admitted After Choking Spell

We'll reach out to this number within 24 hrs